Increased Expression of Bypasses to Drive 46,XX Testicular Development: A New Mechanism of 46,XX DSD
Leah Ragno,Louisa Pyle,Daphne Yang,Trisha R. Bhatti,Jonathan Bradfield,Diane K. Bowen,Katheryn L. Grand,Hakon Hakonarson,Thomas F. Kolon,Joseph Glessner,M. Celeste Simon,Nicolas Skuli,Maria G. Vogiatzi,Marie A. Guerraty,Matthew A. Deardorff
DOI: https://doi.org/10.1101/2024.05.27.24307993
2024-05-28
Abstract:We present a patient with a novel cause of 46,XX ambiguous/androgenous genitalia Differences of Sex Development (DSD). Genome-wide array from blood showed 46,XX with ~35% mosaic duplication of 76.5 Mb at chromosome 8q13.2-q24.3, containing 257 OMIM genes including and . Congenital adrenal hyperplasia testing was negative, testosterone was elevated, and the pro-testicular master regulator was absent. The infant had a uterus, one streak ovary (<5% 8q duplication), and one testicle (75% 8q duplication). We hypothesized that mosaic duplication resulted in localized ZFPM2 overexpression and testicular development. In typical testicular development, ZFPM2 and its binding partner, GATA4, drive expression of the master regulator. We completed RNA-seq of four Formalin-Fixed Paraffin-Embedded (FFPE) gonadal tissue samples from this mosaic individual to identify differentially expressed genes (DEGs). After quality control, two lines representing with and without the duplication were analyzed. In gonadal tissue containing the duplication, increased dosage of in a -negative-46-XX individual appears to upregulate transcriptional activity of gonadal specific promoters such as SOX9 and AMH via its protein interaction with known regulator of early testis development GATA4. SOX9 (FC=39.2, =6.1x10 ) and SF-1 (FC=1.4, =1.6x10 ) interact to produce the functional marker of fetal Sertoli cells, AMH (FC=108.4, =3.0x10 ), and inhibit female sexual differentiation. Several components of the testicular sex-development pathway were upregulated in addition to SOX9 and AMH, including the pro-testicular transcription factor MAP3K1 (FC=1.7, =5.6x10 ), DMRT1 (FC=13.9, =2.1x10 ), LHX9 (FC=2.5, =5.0x10 ), DHH (FC=12.0, =1.8x10 ), PTGDS (FC=2.5, =3.4x10 ), and SOX8 (FC=10.9, =6.5x10 ). may function as a master temporal and spatial regulator of mammalian testicular organogenesis whose increased dosage elicits significant and cascading downstream effects. Further, components of the ovarian WNT-signaling pathway were repressed, including LEF1 (FC=-3.7, =1.4x10 ) and FOXL2 (FC=-8.1, =2.9x10 ). We have shown that increased dosage can induce 46,XX testicular development in a manner not dependent on . This contravenes the previous understanding that GATA4/ZFPM2 drives testicular development through . may modulate numerous critical sex-development genes including transcription factors otherwise thought to be downstream of (MAP3K1, SOX9, AMH). Findings from this single high-yield patient demonstrate that the primary role of in testicular development may be independent of . This adds to the brief (<10) list of genes capable of directing testicular development in the 46,XX context, absent SRY. Overall, new understanding of these genes demonstrates that the role of SRY as a master regulator of testicular development may be less than previously thought.